pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation

References

• JaiswalPGidwaniBVyasANanostructured lipid carriers and their current application in targeted drug deliveryArtif Cells Nanomed Biotechnol2016441274024813223
   PubMed Web of Science ®Google Scholar
• WangGWangJWuWTony ToSSZhaoHWangJAdvances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugsExpert Opin Drug Deliv20151291475149925843160
   PubMed Web of Science ®Google Scholar
• LiuDZhangNCancer chemotherapy with lipid-based nanocarriersCrit Rev Ther Drug Carrier Syst201027537141721083528
   PubMed Web of Science ®Google Scholar
• LeeSGKimCHSungSWRIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cellsInt J Nanomedicine2018133263327829910614
   PubMed Web of Science ®Google Scholar
• ShiJKantoffPWWoosterRFarokhzadOCCancer nanomedicine: progress, challenges and opportunitiesNat Rev Cancer2017171203727834398
   PubMed Web of Science ®Google Scholar
• OwensDEPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMed Web of Science ®Google Scholar
• CheJOkekeCIHuZBXuJDSPE-PEG: a distinctive component in drug delivery systemCurr Pharm Des201521121598160525594410
   PubMed Web of Science ®Google Scholar
• KimCHLeeSGKangMJLeeSChoiYWSurface modification of lipid-based nanocarriers for cancer cell-specific drug targetingJ Pharm Investig2017473203227
   Google Scholar
• FangYXueJGaoSCleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug deliveryDrug Deliv201724Suppl 1223229069920
   PubMedGoogle Scholar
• KorenEApteAJaniATorchilinVPMultifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicityJ Control Release2012160226427322182771
   PubMed Web of Science ®Google Scholar
• ZhangLWangYYangYHigh tumor penetration of paclitaxel loaded pH sensitive cleavable liposomes by depletion of tumor collagen I in breast cancerACS Appl Mater Interfaces20157189691970125845545
   PubMed Web of Science ®Google Scholar
• DingYSunDWangGLAn efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug deliveryInt J Nanomedicine2015106199621426491292
   PubMed Web of Science ®Google Scholar
• BruunJLarsenTBJølckRIInvestigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cellsInt J Nanomedicine2015105995600826451106
   PubMed Web of Science ®Google Scholar
• HatakeyamaHAkitaHItoESystemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipidBiomaterials201132184306431621429576
   PubMed Web of Science ®Google Scholar
• KulkarniPSHaldarMKNahireRRMmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancerMol Pharm20141172390239924827725
   PubMedGoogle Scholar
• McneeleyKMKarathanasisEAnnapragadaAVBellamkondaRVMasking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumorsBiomaterials20093023–243986399519427688
   PubMed Web of Science ®Google Scholar
• OumzilKKhiatiSGrinstaffMWBarthélémyPReduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coatingJ Control Release2011151212313021354443
   PubMed Web of Science ®Google Scholar
• WangHSunMLiDYangXHanCPanWRedox sensitive PEG controlled octaarginine and targeting peptide comodified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivoArtif Cells Nanomed Biotechnol201846231332228362124
   PubMed Web of Science ®Google Scholar
• MoRGuZTumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug deliveryMater Today2016195274283
   Web of Science ®Google Scholar
• GullottiEYeoYExtracellularly activated nanocarriers: a new paradigm of tumor targeted drug deliveryMol Pharm2009641041105119366234
   PubMed Web of Science ®Google Scholar
• RombergBHenninkWEStormGSheddable coatings for long-circulating nanoparticlesPharm Res2008251557117551809
   PubMed Web of Science ®Google Scholar
• KangMHParkMJYooHJRIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cellsEur J Pharm Biopharm201487348949924704199
   PubMed Web of Science ®Google Scholar
• WangCWangXZhongTThe antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivoInt J Nanomedicine2015102229224825834435
   PubMed Web of Science ®Google Scholar
• KaleAATorchilinVPDesign, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugatesBioconjug Chem200718236337017309227
   PubMed Web of Science ®Google Scholar
• LuoQZhaoJZhangXPanWNanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery systemInt J Pharm20114031–218519120951778
   PubMed Web of Science ®Google Scholar
• ShinDHXuanSKimW-YBaeG-UKimJ-SCD133 antibody-conjugated immunoliposomes encapsulating gemcitabine for targeting glioblastoma stem cellsJ Mater Chem B201422437713781
   PubMed Web of Science ®Google Scholar
• GloraniGMarinRCantonPPegylated silica nanoparticles: cytotoxicity and macrophage uptakeJ Nanoparticle Res2017198294
   Web of Science ®Google Scholar
• ShenMHuangYHanLMultifunctional drug delivery system for targeting tumor and its acidic microenvironmentJ Control Release2012161388489222587941
   PubMed Web of Science ®Google Scholar
• YoonHYKwakSSJangMHDocetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: drug release, cytotoxicity, and antitumor efficacyInt J Pharm2017523122923728341149
   PubMedGoogle Scholar
• BaekNSeoOWKimMHulmeJAnSSSsaAMonitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-timeOnco Targets Ther201697207721827920558
   PubMed Web of Science ®Google Scholar
• RabanelJMHildgenPBanquyXAssessment of PEG on polymeric particles surface, a key step in drug carrier translationJ Control Release2014185718724768790
   PubMed Web of Science ®Google Scholar
• TangJFuHKuangQLiposomes comodified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug deliveryJ Drug Target201422431332624404866
   PubMed Web of Science ®Google Scholar
• SawantRMHurleyJPSalmasoS“SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriersBioconjug Chem200617494394916848401
   PubMed Web of Science ®Google Scholar
• EssaSRabanelJMHildgenPCharacterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting densityInt J Pharm20114111–217818721458551
   PubMed Web of Science ®Google Scholar
• JangMHKimCHYoonHYSteric stabilization of RIPL peptide- conjugated liposomes and in vitro assessmentJ Pharm Investig2018541111
   Google Scholar
• HowardMDJayMDziublaTDLuXPEGylation of nanocarrier drug delivery systems: state of the artJ Biomed Nanotechnol200842133148
   Web of Science ®Google Scholar
• LiSDHuangLStealth nanoparticles: high density but sheddable PEG is a key for tumor targetingJ Control Release2010145317818120338200
   PubMed Web of Science ®Google Scholar
• LiuYRanRChenJPaclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targetingBiomaterials201435174835484724651033
   PubMed Web of Science ®Google Scholar
• GöppertTMMüllerRHPolysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patternsJ Drug Target200513317918716036306
   PubMed Web of Science ®Google Scholar
• WanFYouJSunYStudies on PEG-modified SLNs loading vinorelbinebitartrate (I): preparation and evaluation in vitroInt J Pharm20083591–210411018450394
   PubMed Web of Science ®Google Scholar
• LimSBBanerjeeAÖnyükselHImprovement of drug safety by the use of lipid-based nanocarriersJ Control Release20121631344522698939
   PubMed Web of Science ®Google Scholar
• ImmordinoMLDosioFCattelLStealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialInt J Nanomedicine20061329731517717971
   PubMed Web of Science ®Google Scholar
• PageHFloodPReynaudEGThree-dimensional tissue cultures: current trends and beyondCell Tissue Res2013352112313122729488
   PubMed Web of Science ®Google Scholar
• MillardMYakavetsIZorinVKulmukhamedovaAMarchalSBezdetnayaLDrug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screeningInt J Nanomedicine2017127993800729184400
   PubMed Web of Science ®Google Scholar
• HuangBWGaoJQApplication of 3D cultured multicellular spheroid tumor models in tumor-targeted drug delivery system researchJ Control Release201827024625929233763
   PubMed Web of Science ®Google Scholar
• WanXLiZYeHCuiZThree-dimensional perfused tumour spheroid model for anti-cancer drug screeningBiotechnolLett201638813891395
   Google Scholar
• WangXZhenXWangJZhangJWuWJiangXDoxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticlesBiomaterials201334194667467923537667
   PubMed Web of Science ®Google Scholar
• PercheFTorchilinVPCancer cell spheroids as a model to evaluate chemotherapy protocolsCancer BiolTher2012131212051213
   Google Scholar
• BreslinSO’DriscollLThree-dimensional cell culture: the missing link in drug discoveryDrug Discov Today2013185–624024923073387
   PubMed Web of Science ®Google Scholar
• BiswasSDeshpandePPPercheFDodwadkarNSSaneSDTorchilinVPOcta-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancerCancer Lett2013335119120023419527
   PubMed Web of Science ®Google Scholar
• MeiLFuLShiKIncreased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEGInt J Pharm20144681–2263824709209
   PubMed Web of Science ®Google Scholar